Biotechnology Value Trading Fund OS LP, Director Other at Kymera Therapeutics, Inc. (KYMR), bought 545,534 shares at $37.76 ($20.6M) on 2022-01-24, disclosed to the SEC on 2022-01-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.76 | 114,726 | $4.3M | 21.0% |
| 2 | $37.76 | 114,726 | $4.3M | 21.0% |
| 3 | $37.76 | 158,041 | $6.0M | 29.0% |
| 4 | $37.76 | 158,041 | $6.0M | 29.0% |
| Total | $37.76 avg | 545,534 | $20.6M | 100% |
| Filing → |
| RPTX | BUY | 2023-11-03 | $5.6M | — | Filing → |
| OLMA | BUY | 2023-09-14 | $29.6M | — | Filing → |
| OLMA | BUY | 2022-06-14 | $1.6M | — | Filing → |